Hyundai Pharm (004310) — Strategic Asset Allocation Index
Hyundai Pharm (004310) has a Strategic Asset Allocation Index of 38.7% as of November 2013. Strategic assets (PP&E of ₩33.35 Billion plus long-term investments of ₩5.83 Billion) total ₩39.18 Billion, measured against net assets of ₩101.21 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 004310 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Hyundai Pharm Strategic Asset Allocation Index (2010–2013)
This chart shows how Hyundai Pharm's Strategic Asset Allocation Index has evolved across 4 annual periods from 2010 to 2013. As of November 2013, the index stands at 38.7%, representing strategic assets of ₩39.18 Billion against net assets of ₩101.21 Billion KRW. For live market cap and overall valuation, see Hyundai Pharm market capitalisation.
Annual Strategic Asset Allocation Index for Hyundai Pharm (2010–2013)
The table below presents the year-by-year Strategic Asset Allocation Index for Hyundai Pharm from 2010 to 2013, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Hyundai Pharm (004310) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2013 | 38.7% | ₩39.18 Billion | ₩33.35 Billion | ₩5.83 Billion | ₩101.21 Billion | ▲ +0.0 pp |
| 2012 | 38.7% | ₩38.57 Billion | ₩33.10 Billion | ₩5.47 Billion | ₩99.69 Billion | ▼ -4.0 pp |
| 2011 | 42.7% | ₩44.52 Billion | ₩40.73 Billion | ₩3.80 Billion | ₩104.32 Billion | ▼ -11.9 pp |
| 2010 | 54.6% | ₩50.49 Billion | ₩43.17 Billion | ₩7.32 Billion | ₩92.50 Billion | — |